Pilot study of the effect of therapeutic photobiomodulation on postoperative pain in knee arthroplasty

Braz J Anesthesiol. 2022 Jan-Feb;72(1):159-161. doi: 10.1016/j.bjane.2021.07.040. Epub 2021 Nov 17.

Abstract

Nine participants undergoing primary TKA submitted to spinal anesthesia, sedation, ultrasound-guided obturator and Femoral nerve Block analgesia, and photobiomodulation Therapy (FBMT) were evaluated regarding postoperative pain and morphine consumption. FBMT sessions were performed in the Immediate Postoperative period (IPO) and after 24 hours. Participants received 16.7±15 mg of morphine up to the third postoperative day. At IPO, mean pain score was 4.8±3.2 and 5.6±3.5, at rest and on movement, respectively. Photo biomodulation therapy can be considered an option for mitigating pain for patients undergoing TKA.

Trial registration: ClinicalTrials.gov NCT04190797.

Keywords: Analgesia; Osteoarthritis of the knee; Postoperative pain; Therapeutic photobiomodulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Anesthetics, Local / therapeutic use
  • Arthroplasty, Replacement, Knee*
  • Femoral Nerve
  • Humans
  • Morphine / therapeutic use
  • Nerve Block*
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / prevention & control
  • Pilot Projects

Substances

  • Analgesics, Opioid
  • Anesthetics, Local
  • Morphine

Associated data

  • ClinicalTrials.gov/NCT04190797